Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Zidovudine | hsa00030 | Pentose phosphate pathway | 3.06E-04 | 3 | P60891, P51854, P37837 | PRPS1, TKTL1, TALDO1 | More | | Zidovudine | hsa00052 | Galactose metabolism | 4.27E-02 | 2 | P06280, O43451 | GLA, MGAM | More | | Zidovudine | hsa00240 | Pyrimidine metabolism | 8.44E-04 | 4 | P31350, P21589, P32320, P04183 | RRM2, NT5E, CDA, TK1 | More | | Zidovudine | hsa00500 | Starch and sucrose metabolism | 6.17E-03 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Zidovudine | hsa00561 | Glycerolipid metabolism | 2.51E-02 | 2 | P51648, P23743 | ALDH3A2, DGKA | More | | Zidovudine | hsa00562 | Inositol phosphate metabolism | 7.30E-04 | 4 | P27987, Q96PE3, P19174, P42338 | ITPKB, INPP4A, PLCG1, PIK3CB | More | | Zidovudine | hsa00620 | Pyruvate metabolism | 2.51E-02 | 2 | P40925, P51648 | MDH1, ALDH3A2 | More | | Zidovudine | hsa00630 | Glyoxylate and dicarboxylate metabolism | 2.78E-03 | 2 | P40925, P15104 | MDH1, GLUL | More | | Zidovudine | hsa00640 | Propanoate metabolism | 3.83E-02 | 2 | Q02252, Q9P2R7 | ALDH6A1, SUCLA2 | More | | Zidovudine | hsa00730 | Thiamine metabolism | 2.27E-02 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Zidovudine | hsa00983 | Drug metabolism - other enzymes | 3.83E-04 | 4 | P04183, P32320, P31350, P05164 | TK1, CDA, RRM2, MPO | More | | Zidovudine | hsa01100 | Metabolic pathways | 4.12E-02 | 12 | P15104, P51648, P42338, Q96PE3, P19174, P27987, Q13370, P40925, P23743, P43034, P09917, Q53FZ2 | GLUL, ALDH3A2, PIK3CB, INPP4A, PLCG1, ITPKB, PDE3B, MDH1, DGKA, PAFAH1B1, ALOX5, ACSM3 | More | | Zidovudine | hsa01200 | Carbon metabolism | 4.32E-02 | 3 | P51854, P37837, P60891 | TKTL1, TALDO1, PRPS1 | More | | Zidovudine | hsa01230 | Biosynthesis of amino acids | 2.60E-02 | 3 | P51854, P60891, P37837 | TKTL1, PRPS1, TALDO1 | More | | Zidovudine | hsa01521 | EGFR tyrosine kinase inhibitor resistance | 7.30E-04 | 4 | Q92529, P19174, P42338, Q9NRA1 | SHC3, PLCG1, PIK3CB, PDGFC | More | | Zidovudine | hsa03010 | Ribosome | 1.88E-02 | 6 | P62753, P25398, P32969, P62829, P18077, P36578 | RPS6, RPS12, RPL9, RPL23, RPL35A, RPL4 | More | | Zidovudine | hsa03020 | RNA polymerase | 3.22E-03 | 3 | P30876, P24928, P62487 | POLR2B, POLR2A, POLR2G | More | | Zidovudine | hsa04010 | MAPK signaling pathway | 1.53E-02 | 2 | Q9H2K8, Q12933 | TAOK3, TRAF2 | More | | Zidovudine | hsa04012 | ErbB signaling pathway | 9.49E-03 | 3 | Q92529, P19174, P42338 | SHC3, PLCG1, PIK3CB | More | | Zidovudine | hsa04014 | Ras signaling pathway | 2.29E-04 | 7 | P42338, Q92529, Q9NRA1, P49767, P63218, P50151, P19174 | PIK3CB, SHC3, PDGFC, VEGFC, GNG5, GNG10, PLCG1 | More | | Zidovudine | hsa04015 | Rap1 signaling pathway | 3.91E-02 | 4 | Q9NRA1, P49767, P42338, P19174 | PDGFC, VEGFC, PIK3CB, PLCG1 | More | | Zidovudine | hsa04020 | Calcium signaling pathway | 2.16E-02 | 4 | P27987, P19174, Q9NRA1, P49767 | ITPKB, PLCG1, PDGFC, VEGFC | More | | Zidovudine | hsa04022 | cGMP-PKG signaling pathway | 2.55E-02 | 4 | P18848, Q8WYR1, P05141, P0DP24 | ATF4, PIK3R5, SLC25A5, CALM2 | More | | Zidovudine | hsa04062 | Chemokine signaling pathway | 4.35E-03 | 6 | P07948, P42338, P19174, Q92529, P63218, P50151 | LYN, PIK3CB, PLCG1, SHC3, GNG5, GNG10 | More | | Zidovudine | hsa04064 | NF-kappa B signaling pathway | 1.98E-03 | 7 | P10415, P51617, Q04759, Q9UDY8, Q13315, P24522, P09341 | BCL2, IRAK1, PRKCQ, MALT1, ATM, GADD45A, CXCL1 | More | | Zidovudine | hsa04070 | Phosphatidylinositol signaling system | 3.19E-04 | 5 | P19174, P42338, P23743, Q96PE3, P27987 | PLCG1, PIK3CB, DGKA, INPP4A, ITPKB | More | | Zidovudine | hsa04071 | Sphingolipid signaling pathway | 6.68E-04 | 6 | P21453, Q9H228, P01375, Q13362, Q12933, Q02156 | S1PR1, EDG8, TNF, PPP2R5C, TRAF2, PRKCE | More | | Zidovudine | hsa04072 | Phospholipase D signaling pathway | 1.85E-04 | 6 | P42338, Q92529, P19174, Q14344, P23743, Q9NRA1 | PIK3CB, SHC3, PLCG1, GNA13, DGKA, PDGFC | More | | Zidovudine | hsa04080 | Neuroactive ligand-receptor interaction | 1.97E-02 | 5 | P28472, P21453, Q9H228, P21730, P07550 | GABRB3, S1PR1, EDG8, C5AR1, ADRB2 | More | | Zidovudine | hsa04115 | p53 signaling pathway | 3.35E-03 | 5 | P24522, Q13315, P31350, O95067, P10415 | GADD45A, ATM, RRM2, CCNB2, BCL2 | More | | Zidovudine | hsa04141 | Protein processing in endoplasmic reticulum | 4.88E-02 | 4 | P18848, O60337, P11142, P07900 | ATF4, MARH6, HSPA8, HSP90AA1 | More | | Zidovudine | hsa04145 | Phagosome | 1.73E-03 | 6 | Q15080, P68371, P05164, P78380, P35443, P13765 | NCF4, TUBB2C, MPO, OLR1, THBS4, HLA-DOB | More | | Zidovudine | hsa04151 | PI3K-Akt signaling pathway | 6.21E-05 | 15 | P62753, P42338, O43521, P27348, Q9NRA1, P49767, P08238, Q8WYR1, P63218, P50151, O15335, P14784, P18848, O00141, Q6ZUJ8 | RPS6, PIK3CB, BCL2L11, YWHAQ, PDGFC, VEGFC, HSP90AB1, PIK3R5, GNG5, GNG10, CHAD, IL2RB, ATF4, SGK, PIK3AP1 | More | | Zidovudine | hsa04210 | Apoptosis | 3.63E-02 | 3 | O75460, O43521, P18848 | ERN1, BCL2L11, ATF4 | More | | Zidovudine | hsa04217 | Necroptosis | 8.73E-06 | 7 | P07900, P15104, P05141, P01584, P0C0S5, Q13557, Q9H444 | HSP90AA1, GLUL, SLC25A5, IL1B, H2AFZ, CAMK2D, CHMP4B | More | | Zidovudine | hsa04261 | Adrenergic signaling in cardiomyocytes | 2.95E-02 | 4 | P07550, P22694, P18848, Q13362 | ADRB2, PRKACB, ATF4, PPP2R5C | More | | Zidovudine | hsa04370 | VEGF signaling pathway | 1.56E-02 | 2 | P19174, P42338 | PLCG1, PIK3CB | More | | Zidovudine | hsa04371 | Apelin signaling pathway | 1.24E-02 | 4 | P63218, P50151, Q13370, Q14344 | GNG5, GNG10, PDE3B, GNA13 | More | | Zidovudine | hsa04380 | Osteoclast differentiation | 1.02E-02 | 6 | Q9UQC2, Q16539, P14778, O75015, P01375, Q8N149 | GAB2, MAPK14, IL1R1, FCGR3B, TNF, LILRA2 | More | | Zidovudine | hsa04510 | Focal adhesion | 1.55E-02 | 5 | P42338, O15335, Q9NRA1, P49767, Q92529 | PIK3CB, CHAD, PDGFC, VEGFC, SHC3 | More | | Zidovudine | hsa04611 | Platelet activation | 4.11E-02 | 3 | P42338, Q14344, P07948 | PIK3CB, GNA13, LYN | More | | Zidovudine | hsa04612 | Antigen processing and presentation | 2.08E-04 | 8 | P13765, P48382, Q14953, P26715, P26717, Q13241, P01732, P01375 | HLA-DOB, RFX5, KIR2DS5, KLRC1, KLRC2, KLRD1, CD8A, TNF | More | | Zidovudine | hsa04622 | RIG-I-like receptor signaling pathway | 2.47E-02 | 1 | Q12933 | TRAF2 | More | | Zidovudine | hsa04625 | C-type lectin receptor signaling pathway | 3.87E-02 | 4 | Q9ULY5, P20749, P01375, Q16539 | CLEC4E, BCL3, TNF, MAPK14 | More | | Zidovudine | hsa04650 | Natural killer cell mediated cytotoxicity | 5.05E-04 | 7 | P01375, P20963, Q13241, P26718, P26717, Q14953, P26715 | TNF, CD247, KLRD1, KLRK1, KLRC2, KIR2DS5, KLRC1 | More | | Zidovudine | hsa04657 | IL-17 signaling pathway | 8.71E-05 | 9 | P07900, O00463, Q16539, P49841, P19875, P14780, P80188, P01375, P01584 | HSP90AA1, TRAF5, MAPK14, GSK3B, CXCL2, MMP9, LCN2, TNF, IL1B | More | | Zidovudine | hsa04658 | Th1 and Th2 cell differentiation | 1.01E-02 | 4 | P07766, P19174, P14784, Q13761 | CD3E, PLCG1, IL2RB, RUNX3 | More | | Zidovudine | hsa04659 | Th17 cell differentiation | 2.16E-02 | 4 | P19174, P14784, P08238, P07766 | PLCG1, IL2RB, HSP90AB1, CD3E | More | | Zidovudine | hsa04662 | B cell receptor signaling pathway | 2.78E-02 | 3 | P42338, P07948, Q8N149 | PIK3CB, LYN, LILRA2 | More | | Zidovudine | hsa04664 | Fc epsilon RI signaling pathway | 1.34E-04 | 7 | P01375, Q16539, P42338, Q9UQC2, P07948, P19174, P09917 | TNF, MAPK14, PIK3CB, GAB2, LYN, PLCG1, ALOX5 | More | | Zidovudine | hsa04666 | Fc gamma R-mediated phagocytosis | 1.73E-02 | 3 | P07948, P42338, P19174 | LYN, PIK3CB, PLCG1 | More | | Zidovudine | hsa04668 | TNF signaling pathway | 1.71E-04 | 9 | P01375, O00463, Q16539, P18848, P19875, P01584, P20749, P14780, P20333 | TNF, TRAF5, MAPK14, ATF4, CXCL2, IL1B, BCL3, MMP9, TNFRSF1B | More | | Zidovudine | hsa04722 | Neurotrophin signaling pathway | 4.87E-02 | 3 | P42338, P19174, Q92529 | PIK3CB, PLCG1, SHC3 | More | | Zidovudine | hsa04724 | Glutamatergic synapse | 1.73E-02 | 3 | P63218, P50151, P15104 | GNG5, GNG10, GLUL | More | | Zidovudine | hsa04725 | Cholinergic synapse | 1.73E-02 | 3 | P63218, P50151, P42338 | GNG5, GNG10, PIK3CB | More | | Zidovudine | hsa04726 | Serotonergic synapse | 3.41E-02 | 3 | P63218, P50151, P09917 | GNG5, GNG10, ALOX5 | More | | Zidovudine | hsa04727 | GABAergic synapse | 6.57E-03 | 3 | P63218, P50151, P15104 | GNG5, GNG10, GLUL | More | | Zidovudine | hsa04730 | Long-term depression | 1.56E-02 | 2 | Q14344, P07948 | GNA13, LYN | More | | Zidovudine | hsa04910 | Insulin signaling pathway | 4.11E-02 | 3 | Q92529, Q13370, P42338 | SHC3, PDE3B, PIK3CB | More | | Zidovudine | hsa04913 | Ovarian steroidogenesis | 2.54E-02 | 2 | P42330, P22694 | AKR1C3, PRKACB | More | | Zidovudine | hsa04914 | Progesterone-mediated oocyte maturation | 2.22E-02 | 3 | P42338, Q13370, P08238 | PIK3CB, PDE3B, HSP90AB1 | More | | Zidovudine | hsa04915 | Estrogen signaling pathway | 4.76E-03 | 4 | P42338, Q92529, P08238, P11142 | PIK3CB, SHC3, HSP90AB1, HSPA8 | More | | Zidovudine | hsa04923 | Regulation of lipolysis in adipocytes | 3.64E-02 | 2 | Q13370, P42338 | PDE3B, PIK3CB | More | | Zidovudine | hsa04924 | Renin secretion | 4.04E-02 | 2 | P22694, P07550 | PRKACB, ADRB2 | More | | Zidovudine | hsa04926 | Relaxin signaling pathway | 1.18E-04 | 9 | P42338, P63218, P50151, P18848, P22694, P49767, P14780, Q92529, P30679 | PIK3CB, GNG5, GNG10, ATF4, PRKACB, VEGFC, MMP9, SHC3, GNA15 | More | | Zidovudine | hsa04927 | Cortisol synthesis and secretion | 2.54E-02 | 2 | P18848, P22694 | ATF4, PRKACB | More | | Zidovudine | hsa04930 | Type II diabetes mellitus | 2.47E-02 | 1 | Q02156 | PRKCE | More | | Zidovudine | hsa04932 | Non-alcoholic fatty liver disease | 5.73E-05 | 6 | O43521, P18848, O75460, P01584, P13073, O15239 | BCL2L11, ATF4, ERN1, IL1B, COX4I1, NDUFA1 | More | | Zidovudine | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 4.11E-02 | 3 | P42338, P49767, P19174 | PIK3CB, VEGFC, PLCG1 | More | | Zidovudine | hsa04935 | Growth hormone synthesis, secretion and action | 2.78E-02 | 3 | P19174, P42338, Q92529 | PLCG1, PIK3CB, SHC3 | More | | Zidovudine | hsa04970 | Salivary secretion | 1.91E-02 | 3 | P07550, P22694, P49913 | ADRB2, PRKACB, CAMP | More | | Zidovudine | hsa04974 | Protein digestion and absorption | 2.47E-02 | 1 | Q7Z2H8 | SLC36A1 | More | | Zidovudine | hsa05010 | Alzheimer disease | 2.78E-02 | 6 | P13073, O75460, P0DP24, P01584, P18848, P05141 | COX4I1, ERN1, CALM2, IL1B, ATF4, SLC25A5 | More | | Zidovudine | hsa05012 | Parkinson disease | 2.77E-03 | 7 | O15239, P13073, P05141, O75460, P18848, P0DP24, Q13557 | NDUFA1, COX4I1, SLC25A5, ERN1, ATF4, CALM2, CAMK2D | More | | Zidovudine | hsa05016 | Huntington disease | 4.33E-03 | 7 | O15239, P13073, P24928, P30876, P62487, P05141, O75460 | NDUFA1, COX4I1, POLR2A, POLR2B, POLR2G, SLC25A5, ERN1 | More | | Zidovudine | hsa05020 | Prion disease | 3.37E-03 | 7 | P13591, P01584, P11142, O15239, P13073, P18848, P05141 | NCAM1, IL1B, HSPA8, NDUFA1, COX4I1, ATF4, SLC25A5 | More | | Zidovudine | hsa05022 | Pathways of neurodegeneration - multiple diseases | 2.20E-03 | 9 | O15239, P13073, O75460, P18848, P05141, P20333, P01584, P0DP24, Q13557 | NDUFA1, COX4I1, ERN1, ATF4, SLC25A5, TNFRSF1B, IL1B, CALM2, CAMK2D | More | | Zidovudine | hsa05031 | Amphetamine addiction | 4.32E-02 | 3 | P22694, P18848, Q13547 | PRKACB, ATF4, HDAC1 | More | | Zidovudine | hsa05032 | Morphine addiction | 2.22E-02 | 3 | P63218, P50151, Q13370 | GNG5, GNG10, PDE3B | More | | Zidovudine | hsa05100 | Bacterial invasion of epithelial cells | 3.64E-02 | 2 | P42338, Q92529 | PIK3CB, SHC3 | More | | Zidovudine | hsa05131 | Shigellosis | 1.65E-02 | 2 | Q12933, Q02156 | TRAF2, PRKCE | More | | Zidovudine | hsa05134 | Legionellosis | 1.28E-02 | 3 | P01584, P68104, P11142 | IL1B, EEF1A1, HSPA8 | More | | Zidovudine | hsa05144 | Malaria | 1.91E-02 | 3 | P01375, P35443, P26718 | TNF, THBS4, KLRK1 | More | | Zidovudine | hsa05146 | Amoebiasis | 2.41E-02 | 4 | P19875, P01375, P30679, P22694 | CXCL2, TNF, GNA15, PRKACB | More | | Zidovudine | hsa05150 | Staphylococcus aureus infection | 1.91E-02 | 4 | Q14532, P59665, P59666, P49913 | KRT32, DEFA1; DEFA1B, DEFA3, CAMP | More | | Zidovudine | hsa05152 | Tuberculosis | 1.95E-02 | 5 | P48382, P10415, P13765, Q9UDY8, P51617 | RFX5, BCL2, HLA-DOB, MALT1, IRAK1 | More | | Zidovudine | hsa05162 | Measles | 4.15E-03 | 6 | P14784, P07766, P42338, P11142, P01584, Q9NP90 | IL2RB, CD3E, PIK3CB, HSPA8, IL1B, RAB9B | More | | Zidovudine | hsa05163 | Human cytomegalovirus infection | 1.10E-03 | 11 | P42338, P01375, P63218, P50151, Q14344, P49841, P14778, P25025, Q16539, O00463, P30101 | PIK3CB, TNF, GNG5, GNG10, GNA13, GSK3B, IL1R1, CXCR2, MAPK14, TRAF5, PDIA3 | More | | Zidovudine | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 1.14E-02 | 5 | P42338, P63218, P50151, P19174, P07948 | PIK3CB, GNG5, GNG10, PLCG1, LYN | More | | Zidovudine | hsa05168 | Herpes simplex virus 1 infection | 4.79E-02 | 8 | P25963, Q07955, Q01130, Q9Y2A4, P51522, P17038, P52738, O75820 | NFKBIA, SFRS1, SFRS2, ZNF443, ZNF83, ZNF43, ZNF140, ZNF189 | More | | Zidovudine | hsa05169 | Epstein-Barr virus infection | 3.34E-02 | 5 | P42338, P07948, P30101, Q13761, P07766 | PIK3CB, LYN, PDIA3, RUNX3, CD3E | More | | Zidovudine | hsa05170 | Human immunodeficiency virus 1 infection | 7.03E-03 | 6 | P42338, P63218, P50151, P30101, P19174, P07766 | PIK3CB, GNG5, GNG10, PDIA3, PLCG1, CD3E | More | | Zidovudine | hsa05171 | Coronavirus disease - COVID-19 | 9.72E-03 | 7 | P01584, P62753, P25398, P36578, P32969, P18077, P62829 | IL1B, RPS6, RPS12, RPL4, RPL9, RPL35A, RPL23 | More | | Zidovudine | hsa05200 | Pathways in cancer | 3.05E-02 | 8 | P42338, P08238, P19174, P49767, P63218, P50151, Q14344, P14784 | PIK3CB, HSP90AB1, PLCG1, VEGFC, GNG5, GNG10, GNA13, IL2RB | More | | Zidovudine | hsa05202 | Transcriptional misregulation in cancer | 3.11E-02 | 7 | Q13315, P14923, Q15744, P05164, P08246, Q9C0K0, P24522 | ATM, JUP, CEBPE, MPO, ELA2, BCL11B, GADD45A | More | | Zidovudine | hsa05205 | Proteoglycans in cancer | 3.68E-02 | 5 | P14780, P01375, P23588, Q13635, P22694 | MMP9, TNF, EIF4B, PTCH1, PRKACB | More | | Zidovudine | hsa05214 | Glioma | 9.49E-03 | 3 | Q92529, P42338, P19174 | SHC3, PIK3CB, PLCG1 | More | | Zidovudine | hsa05215 | Prostate cancer | 4.87E-02 | 3 | Q9NRA1, P08238, P42338 | PDGFC, HSP90AB1, PIK3CB | More | | Zidovudine | hsa05218 | Melanoma | 3.64E-02 | 2 | Q9NRA1, P42338 | PDGFC, PIK3CB | More | | Zidovudine | hsa05221 | Acute myeloid leukemia | 3.29E-02 | 3 | P14923, Q15744, P05164 | JUP, CEBPE, MPO | More | | Zidovudine | hsa05231 | Choline metabolism in cancer | 1.17E-03 | 4 | P42338, Q9NRA1, P19174, P23743 | PIK3CB, PDGFC, PLCG1, DGKA | More | | Zidovudine | hsa05310 | Asthma | 3.01E-02 | 2 | P13765, P12724 | HLA-DOB, RNASE3 | More | | Zidovudine | hsa05321 | Inflammatory bowel disease | 1.91E-02 | 3 | P01375, Q14765, Q9UL17 | TNF, STAT4, TBX21 | More | | Zidovudine | hsa05332 | Graft-versus-host disease | 8.79E-03 | 3 | P01375, P26715, Q13241 | TNF, KLRC1, KLRD1 | More | | Zidovudine | hsa05415 | Diabetic cardiomyopathy | 2.87E-02 | 4 | P05141, O15239, P13073, Q13557 | SLC25A5, NDUFA1, COX4I1, CAMK2D | More | | Zidovudine | hsa05418 | Fluid shear stress and atherosclerosis | 1.08E-03 | 7 | Q16539, Q14145, P10599, P14780, P01375, P14778, P27930 | MAPK14, KEAP1, TXN, MMP9, TNF, IL1R1, IL1R2 | More | | |